Global Next-generation Sequencing Data Analysis Market Size Study, by Product (Services, NGS Commercial Software), by Workflow (Primary, Secondary, Tertiary), by Mode (In-house, Outsourced), by Read Length, by End Use, and Regional Forecasts 2022-2032

January 2025 | 285 pages | ID: GDCD1C7BD97EEN
Bizwit Research & Consulting LLP

US$ 3,218.00 US$ 4,950.00 -35 %
Offer valid until August 31, 2025!

E-mail Delivery (PDF), Hard Copy Mail Delivery

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The global Next-generation Sequencing (NGS) Data Analysis Market was valued at approximately USD 811.86 million in 2023 and is projected to exhibit a robust compound annual growth rate (CAGR) of 23.10% during the forecast period from 2024 to 2032. NGS technology has revolutionized genomic research and diagnostics, offering unprecedented insights into complex biological phenomena. The decreasing cost of sequencing platforms, coupled with significant advancements in bioinformatics tools, has facilitated broader adoption in clinical and research settings.

The market is driven by the growing demand for efficient and scalable data analysis tools, particularly as NGS applications extend into oncology, rare disease diagnostics, and personalized medicine. Cloud-based bioinformatics platforms are gaining prominence for their ability to manage extensive genomic datasets with enhanced cost efficiency. Additionally, the advent of user-friendly software solutions, such as CLC Genomics Workbench and SevenBridges, has simplified complex genomic workflows, further boosting market penetration.

The market dynamics were notably influenced by the COVID-19 pandemic, as NGS technologies were pivotal in tracking viral mutations, developing diagnostics, and expediting vaccine research. These applications underscored the importance of robust sequencing data analysis tools, leading to increased investments from public and private sectors globally. Concurrently, advancements in tertiary data analysis have enabled deeper insights into genomic variation and functional genomics, facilitating novel therapeutic strategies.

While North America dominates the market owing to its advanced healthcare infrastructure and high R&D investments, Asia-Pacific is anticipated to experience the fastest growth due to rising adoption of precision medicine and increasing funding for genomic initiatives. In regions like China and India, government initiatives are actively promoting NGS adoption for tackling chronic diseases and enhancing healthcare delivery systems.

The market comprises leading players including Thermo Fisher Scientific, QIAGEN, Illumina, and Agilent Technologies, which continue to expand their portfolios with cutting-edge solutions tailored to diverse end-use applications.

Major market players included in this report are:

1. Thermo Fisher Scientific, Inc.

2. QIAGEN

3. Illumina, Inc.

4. Agilent Technologies Inc.

5. Pacific Biosciences of California, Inc.

6. Bio-Rad Laboratories, Inc.

7. F. Hoffmann-La Roche Ltd.

8. Eurofins Scientific

9. Partek Incorporated

10. DNASTAR, Inc.

11. SevenBridges Genomics

12. DNAnexus

13. Genedata AG

14. PerkinElmer Inc.

15. BaseSpace

The detailed segments and sub-segments of the market are explained below:

By Product:
  • Services
  • NGS Commercial Software
  • Platform OS/UI
  • Analytical Software
  • QC/Pre-processing Tools
  • Alignment Tools & Software
  • Others
By Workflow:
  • Primary
  • Secondary
  • Read Mapping
  • Variant Alignment & Variant Calling
  • Tertiary
  • Variant Annotation
  • Application Specific
By Mode:
  • In-house
  • Outsourced
By Read Length:
  • Short Read Sequencing
  • Long Read Sequencing
  • Very Long Read Sequencing
By End Use:
  • Academic Research
  • Clinical Research
  • Hospitals & Clinics
  • Pharma & Biotech Entities
  • Other Users
By Region:

North America
  • U.S.
  • Canada
  • Mexico
Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Thailand
Latin America
  • Brazil
  • Argentina
Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait
Years considered for the study are as follows:
  • Historical year – 2022
  • Base year – 2023
  • Forecast period – 2024 to 2032
Key Takeaways:
  • Market Estimates & Forecast for 10 years from 2022 to 2032.
  • Annualized revenues and regional-level analysis for each market segment.
  • Detailed analysis of geographical landscape with country-level analysis of major regions.
  • Competitive landscape with information on major players in the market.
  • Analysis of key business strategies and recommendations on future market approaches.
  • Analysis of the competitive structure of the market.
  • Demand-side and supply-side analysis of the market.
CHAPTER 1. GLOBAL NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET EXECUTIVE SUMMARY

1.1. Global Next-generation Sequencing Data Analysis Market Size & Forecast (2022-2032)
1.2. Regional Summary
1.3. Segmental Summary
  1.3.1. By Product
  1.3.2. By Workflow
  1.3.3. By Mode
  1.3.4. By Read Length
  1.3.5. By End Use
1.4. Key Trends
1.5. Recession Impact
1.6. Analyst Recommendation & Conclusion

CHAPTER 2. GLOBAL NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET DEFINITION AND RESEARCH ASSUMPTIONS

2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
  2.3.1. Inclusion & Exclusion
  2.3.2. Limitations
  2.3.3. Supply Side Analysis
    2.3.3.1. Availability
    2.3.3.2. Infrastructure
    2.3.3.3. Regulatory Environment
    2.3.3.4. Market Competition
    2.3.3.5. Economic Viability (Consumer’s Perspective)
  2.3.4. Demand Side Analysis
    2.3.4.1. Regulatory Frameworks
    2.3.4.2. Technological Advancements
    2.3.4.3. Environmental Considerations
    2.3.4.4. Consumer Awareness & Acceptance
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates

CHAPTER 3. GLOBAL NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET DYNAMICS

3.1. Market Drivers
  3.1.1. Growing adoption in personalized medicine
  3.1.2. Rising demand for efficient data management systems
  3.1.3. Advances in cloud-based platforms
3.2. Market Challenges
  3.2.1. High costs of data analysis infrastructure
  3.2.2. Data management complexities
3.3. Market Opportunities
  3.3.1. Increasing use in oncology and rare disease research
  3.3.2. Technological innovations in tertiary analysis

CHAPTER 4. GLOBAL NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET INDUSTRY ANALYSIS

4.1. Porter’s 5 Force Model
  4.1.1. Bargaining Power of Suppliers
  4.1.2. Bargaining Power of Buyers
  4.1.3. Threat of New Entrants
  4.1.4. Threat of Substitutes
  4.1.5. Competitive Rivalry
  4.1.6. Futuristic Approach to Porter’s 5 Force Model
  4.1.7. Porter’s 5 Force Impact Analysis
4.2. PESTEL Analysis
  4.2.1. Political
  4.2.2. Economical
  4.2.3. Social
  4.2.4. Technological
  4.2.5. Environmental
  4.2.6. Legal
4.3. Top Investment Opportunities
4.4. Top Winning Strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion

CHAPTER 5. GLOBAL NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE & FORECASTS BY PRODUCT (2022-2032)

5.1. Segment Dashboard
5.2. Global Next-generation Sequencing Data Analysis Market: Product Revenue Trend Analysis, 2022 & 2032 (USD Million)
  5.2.1. Services
  5.2.2. NGS Commercial Software
    5.2.2.1. Platform OS/UI
    5.2.2.2. Analytical Software
    5.2.2.3. QC/Pre-processing Tools
    5.2.2.4. Alignment Tools & Software
      5.2.2.4.1. DNA Sequencing Alignment
      5.2.2.4.2. RNA Sequencing Alignment
      5.2.2.4.3. Protein Sequencing Alignment
    5.2.2.5. Others

CHAPTER 6. GLOBAL NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE & FORECASTS BY WORKFLOW (2022-2032)

6.1. Segment Dashboard
6.2. Global Next-generation Sequencing Data Analysis Market: Workflow Revenue Trend Analysis, 2022 & 2032 (USD Million)
  6.2.1. Primary Analysis
  6.2.2. Secondary Analysis
    6.2.2.1. Read Mapping
    6.2.2.2. Variant Alignment & Variant Calling
  6.2.3. Tertiary Analysis
    6.2.3.1. Variant Annotation
    6.2.3.2. Application-Specific Workflows
      6.2.3.2.1. Targeted Sequencing/Gene Panel
      6.2.3.2.2. Exome Sequencing
      6.2.3.2.3. RNA Sequencing
      6.2.3.2.4. Whole Genome Sequencing
      6.2.3.2.5. Chip Sequencing
      6.2.3.2.6. Others

CHAPTER 7. GLOBAL NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE & FORECASTS BY MODE (2022-2032)

7.1. Segment Dashboard
7.2. Global Next-generation Sequencing Data Analysis Market: Mode Revenue Trend Analysis, 2022 & 2032 (USD Million)
  7.2.1. In-house
  7.2.2. Outsourced

CHAPTER 8. GLOBAL NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE & FORECASTS BY READ LENGTH (2022-2032)

8.1. Segment Dashboard
8.2. Global Next-generation Sequencing Data Analysis Market: Read Length Revenue Trend Analysis, 2022 & 2032 (USD Million)
  8.2.1. Short Read Sequencing
  8.2.2. Long Read Sequencing
  8.2.3. Very Long Read Sequencing

CHAPTER 9. GLOBAL NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE & FORECASTS BY END USE (2022-2032)

9.1. Segment Dashboard
9.2. Global Next-generation Sequencing Data Analysis Market: End Use Revenue Trend Analysis, 2022 & 2032 (USD Million)
  9.2.1. Academic Research
  9.2.2. Clinical Research
  9.2.3. Hospitals & Clinics
  9.2.4. Pharma & Biotech Entities
  9.2.5. Other Users

CHAPTER 10. GLOBAL NEXT-GENERATION SEQUENCING DATA ANALYSIS MARKET SIZE & FORECASTS BY REGION (2022-2032)

10.1. North America Next-generation Sequencing Data Analysis Market
  10.1.1. U.S.
    10.1.1.1. Product breakdown size & forecasts, 2022-2032
    10.1.1.2. Workflow breakdown size & forecasts, 2022-2032
  10.1.2. Canada
  10.1.3. Mexico
10.2. Europe Next-generation Sequencing Data Analysis Market
  10.2.1. Germany
  10.2.2. UK
  10.2.3. France
  10.2.4. Italy
  10.2.5. Spain
  10.2.6. Rest of Europe
10.3. Asia Pacific Next-generation Sequencing Data Analysis Market
  10.3.1. China
  10.3.2. Japan
  10.3.3. India
  10.3.4. Australia
  10.3.5. South Korea
  10.3.6. Rest of Asia Pacific
10.4. Latin America Next-generation Sequencing Data Analysis Market
  10.4.1. Brazil
  10.4.2. Argentina
  10.4.3. Rest of Latin America
10.5. Middle East & Africa Next-generation Sequencing Data Analysis Market
  10.5.1. Saudi Arabia
  10.5.2. South Africa
  10.5.3. UAE
  10.5.4. Rest of Middle East & Africa

CHAPTER 11. COMPETITIVE INTELLIGENCE

11.1. Key Company SWOT Analysis
  11.1.1. Thermo Fisher Scientific
  11.1.2. Illumina, Inc.
  11.1.3. QIAGEN
11.2. Top Market Strategies
11.3. Company Profiles
  11.3.1. Thermo Fisher Scientific
  11.3.2. QIAGEN
  11.3.3. Agilent Technologies Inc.
  11.3.4. Bio-Rad Laboratories, Inc.
  11.3.5. Pacific Biosciences of California, Inc.
  11.3.6. Eurofins Scientific
  11.3.7. Partek Incorporated
  11.3.8. DNASTAR, Inc.
  11.3.9. SevenBridges Genomics
  11.3.10. DNAnexus
  11.3.11. Genedata AG
  11.3.12. PerkinElmer Inc.
  11.3.13. BaseSpace

CHAPTER 12. RESEARCH PROCESS

12.1. Research Process
  12.1.1. Data Mining
  12.1.2. Analysis
  12.1.3. Market Estimation
  12.1.4. Validation
  12.1.5. Publishing
12.2. Research Attributes

12. LIST OF FIGURES

FIG 1. Global Next-generation Sequencing Data Analysis market, research methodology
FIG 2. Global Next-generation Sequencing Data Analysis market, market estimation techniques
FIG 3. Global Next-generation Sequencing Data Analysis market, key trends 2023
FIG 4. Global Next-generation Sequencing Data Analysis market, growth prospects 2022-2032

This list is not complete, final report does contain more than 50 figures. The list may be updated in the final deliverable.

12. LIST OF TABLES

TABLE 1. Global Next-generation Sequencing Data Analysis market, report scope
TABLE 2. Global Next-generation Sequencing Data Analysis market estimates & forecasts by Region 2022-2032 (USD Million)
TABLE 3. Global Next-generation Sequencing Data Analysis market estimates & forecasts by Product 2022-2032 (USD Million)
TABLE 4. Global Next-generation Sequencing Data Analysis market estimates & forecasts by Workflow 2022-2032 (USD Million)

This list is not complete, final report does contain more than 100 tables. The list may be updated in the final deliverable.


More Publications